Antireflux surgery for patients with end-stage lung disease before and after lung transplantation.
BACKGROUND
Gastroesophageal reflux disease (GERD) is prevalent among patients with end-stage lung disease (ESLD). This disease can lead to microaspiration and may be a risk factor for lung damage before and after transplantation. A fundoplication is the best way to stop reflux, but little is known about the safety of elective antireflux surgery for patients with ESLD. This study aimed to report the safety of laparoscopic fundoplication for patients with ESLD and GERD before or after lung transplantation.


METHODS
Between January 1997 and January 2007, 305 patients were listed for lung transplantation, and 189 patients underwent the procedure. In 2003, routine esophageal studies were added to the pretransplantation evaluation. After the authors' initial experience, gastric emptying studies were added as well.


RESULTS
A total of 35 patients with GERD or delayed gastric emptying were referred for surgical intervention. A laparoscopic fundoplication was performed for 32 patients (27 total and 5 partial). For three patients, a pyloroplasty also was performed. Two patients had a pyloroplasty without fundoplication. Of the 35 operations, 15 were performed before and 20 after transplantation. Gastric emptying of solids or liquids was delayed in 12 (92%) of 13 posttransplantation studies and 3 (60%) of 5 pretransplantation studies. All operations were completed laparoscopically, and 33 patients recovered uneventfully (94%). The median hospital length of stay was 2 days (range, 1-34 days) for the patients admitted to undergo elective operations. Hospitalization was not prolonged for the three patients who had fundoplications immediately after transplantation.


CONCLUSIONS
The results of this study show that laparoscopic antireflux surgery can be performed safely by an experienced multidisciplinary team for selected patients with ESLD before or after lung transplantation, and that gastric emptying is frequently abnormal and should be objectively measured in ESLD patients.
Gasper
W J
WJ
Department of Surgery, University of California San Francisco, 521 Parnassus Avenue, Room C-341, San Francisco, CA 94143, USA.
Sweet
M P
MP
Hoopes
C
C
Leard
L E
LE
Kleinhenz
M E
ME
Hays
S R
SR
Golden
J A
JA
Patti
M G
MG
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D018662:Fundoplication / Q000009:adverse effects / Q000379:methods*; D005764:Gastroesophageal Reflux / Q000150:complications* / Q000601:surgery*; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D008171:Lung Diseases / Q000150:complications* / Q000601:surgery*; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D011708:Pylorus / Q000601:surgery*
Am J Respir Crit Care Med. 1998 Dec;158(6):1804-8
9847271
J Gastrointest Surg. 2004 Nov;8(7):890-7; discussion 897-8
15531244
J Laparoendosc Adv Surg Tech A. 2001 Dec;11(6):327-31
11814122
Surg Endosc. 2001 Mar;15(3):271-4
11344427
Thorac Surg Clin. 2005 Aug;15(3):417-27
16104132
Am J Gastroenterol. 1992 Sep;87(9):1102-11
1519566
Ann Thorac Surg. 2005 Oct;80(4):1254-60
16181849
Eur Respir J. 2006 Jan;27(1):136-42
16387946
Arch Surg. 2006 Mar;141(3):289-92; discussion 292
16549695
Am J Transplant. 2006 Aug;6(8):1930-8
16889547
Ann Surg. 2006 Oct;244(4):491-7
16998357
J Thorac Cardiovasc Surg. 2006 Feb;131(2):438-46
16434276
Chest. 1995 Dec;108(6):1602-7
7497768
Ann Thorac Surg. 2004 Oct;78(4):1142-51; discussion 1142-51
15464462
J Heart Lung Transplant. 2006 Sep;25(9):1077-83
16962469
Surg Endosc. 2007 Feb;21(2):285-8
17122978
Dis Esophagus. 2006;19(5):315-20
16984525